Should You Sell Ocean Biomedical Inc (OCEA) And Go Away This Year?

Ocean Biomedical Inc (NASDAQ:OCEA) currently has a daily average trading volume of 35.54M but it saw 858103034 shares traded in last market. With a market cap of 11.77M USD, the company’s current market price of $0.08 came rising about 47.36 while comparing to the previous closing price of $0.06. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.37 and as low as $0.05. In the recent trading on the day, stock has struck highest price mark of $0.066 while lowest mark touched by it was $0.136.

Taking a look at 20-day trading activity of Ocean Biomedical Inc (OCEA) gives us an average price of $0.0764, while its current price level is -98.08% below from 52-week high level whereas it is 63.80% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.1881 while that of 200 days or SMA-200 reads an average of $0.7721. A closer look into the stock’s movement over the week reveals that its volatility is standing at 36.16% during that period while stretching the period over a month that decreases to 19.76%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 39.81 which implies that the stock is in neutral territory.

Over the week, OCEA’s stock price is moving 38.35% up while it is -20.29% when we observe its performance for the past one month. Year-to-date it is -84.86% down and over the past year, the stock is showing a downside performance of -98.03%.

The company is expected to be releasing its next quarterly report on 2024-Apr-14, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.

Currently, Ocean Biomedical Inc’s total number of outstanding shares is 140.59M with 17.04% of that held by the insiders while 2.60% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -1691.47%. Stock’s beta reads 1.54. Its return on asset (ROA) is -2461.30% on average.

Comet Reports
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.